DCM
LIVN icon

Diag Capital Management’s LivaNova LIVN Stock Holding History

Diag Capital Management’s Portfolio LIVN Stock Details LIVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$1.09M Buy
+11,974
New +$1.29M 1.25% 27

Other funds holding LIVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Diag Capital Management's LIVN Position: Q4 2018 in Review

Diag Capital Management opened a new position in LivaNova (LIVN) in Q4 2018: 11,974 shares worth $1.09M. The stake represents 1.25% of the portfolio and ranks #27 among its holdings.

251 funds tracked by Wall St. Rank hold LIVN as of Q4 2018.

  • Diag Capital Management held 11,974 shares of LivaNova worth $1.09M as of Q4 2018.
  • LivaNova was a new Diag Capital Management position in Q4 2018.
  • LivaNova made up 1.25% of Diag Capital Management's portfolio in Q4 2018, its #27 holding.
  • 251 funds tracked by Wall St. Rank held LivaNova as of Q4 2018.

Based on Diag Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.